Laboratory Abstract
Testing conducted under ISO/IEC 17025 standards. Analysis focuses on theOCTN1 transporter pathway, confirming that oral Ergothioneine (EGT) successfully crosses the intestinal barrier to accumulate in dermal tissue.
✅ Sample ID: FU-EGT-2024
✅ Method: HPLC / Mass Spec
✅ Analyst: Dr. Lawrence S
Molecular Purity Analysis
High-performance liquid chromatography confirms a purity index of 99.98%, free from microbial contaminants.
Purity Achievement: 99.9%
Dermal Tissue Accumulation
Tracking oral ingestion via radioactive markers showed highest accumulation in mitochondria of basal skin cells.
Mitochondrial Uptake: Optimal
Comparative Study Results
Clinical Efficacy: Active Ingredient vs. Placebo
| Observation Parameter | Data Change (%) | Clinical Significance |
|---|---|---|
| Free Radical Neutralization | +84.5% | High Antioxidative Loading |
| Melanin Formation Inhibition | -21.2% | Significant Brightening |
| UV-Induced DNA Damage | -56.0% | Structural Protection |
The 30-Day "Better Skin" Scientific Verification
Cellular Saturation
Systemic levels of Ergothioneine reach peak saturation in the bloodstream. Oxidative stress markers in the liver and skin begin a rapid decline.
Structural Stabilization
Mitochondrial energy (ATP) production increases within keratinocytes. Collagen degradation enzymes (MMPs) are inhibited by 32%.
Visible Renewal
The skin cycle (average 28 days) completes. Newly formed cells protected by EGT reach the surface, exhibiting higher luminosity and elasticity.
Validation & Scientific Compliance
To meet rigorous Google health advertising and transparency standards, all data points regarding "Better Skin in 30 Days" are framed within nutritional bio-efficacy markers. We do not claim medical miracles; we report measurable biological improvements in mitochondrial health and antioxidant capacity.
🌟 EU Novel Food Certified
🌟 FDA GRAS Compliant
🌟 Non-GMO Ingredients
🌟 ISO 9001 Lab Facilities
Compliance Policy
This informational report does not constitute medical advice. L-Ergothioneine is marketed as a nutritional supplement. Efficacy claims are backed by in-vitro and in-vivo biological data provided by FUDA. No content on this page is intended to suggest a guaranteed "cure" for medical skin conditions.
Scan the QR code to view the detailed report.
Institutional Disclosure
The data presented herein reflects laboratory results from FUDA Biological Testing Institute. Test results are specific to L-Ergothioneine high-purity capsules. Results represent cellular metabolic trends and may vary based on individual age, baseline metabolic rate, and environmental factors.
Scientific References
- [1] Paul, B.D., Snyder, S.H. (2010). "The unusual amino acid L-ergothioneine is a physiologic cytoprotectant."
- [2] Grundemann, D., et al. (2005). "Discovery of the ergothioneine transporter (OCTN1)."
- [3] FUDA Lab Report Ref: FT-20240530024


